8 news items
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets – Hagens Berman
ZTS
29 May 24
%) on Apr. 12, 2024. "We are investigating whether Zoetis may have misrepresented the safety of its pet arthritis drugs," said Reed Kathrein
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets – Hagens Berman
ZTS
16 May 24
. "We are investigating whether Zoetis may have misrepresented the safety of its pet arthritis drugs," said Reed Kathrein, the Hagens Berman partner
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman
ZTS
8 May 24
down $12.75 (7.8%) on Apr. 12, 2024. "We are investigating whether Zoetis may have misrepresented the safety of its pet arthritis drugs," said
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman
ZTS
30 Apr 24
down $12.75 (7.8%) on Apr. 12, 2024. "We are investigating whether Zoetis may have misrepresented the safety of its pet arthritis drugs," said
Zoetis (ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman
ZTS
22 Apr 24
are investigating whether Zoetis may have potentially put profits ahead of pet safety," said Reed Kathrein, the Hagens Berman partner leading
vv7 46i7o91e6ea91v
ZTS
15 Apr 24
owners' complaints." "We are investigating whether Zoetis may have potentially put profits ahead of pet safety," said Reed Kathrein, the Hagens
wntqqhlhniw6ipnj7n6b9rcboc6li6tm msi3u69kn
ZTS
12 Apr 24
safety," said Reed Kathrein, the Hagens Berman partner leading the investigation. If you invested in Zoetis and have substantial losses
l4dj7yxhkuw x1od
ADIL
AGEN
AGX
12 Apr 24
highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.
Agenus Inc
- Prev
- 1
- Next